Kent Thoelke

Kent Thoelke is founder and CEO of Paradigm Health, a healthcare technology company that combines a global provider network with an AI-powered research platform to make clinical trials more accessible and efficient, so that patients, researchers, and study sponsors can maximize the impact of clinical research. Thoelke is a 30-year veteran of the clinical research industry, most recently serving as the Chief Innovation Officer at ICON plc following the acquisition of PRA Health Sciences, where he was Chief Scientific Officer. Throughout his career, Thoelke has focused on digital transformation within companies conducting clinical trials, advocating for better use of data to make drug development more efficient and more equitable for patients. His work spans various therapeutic areas and geographic regions, giving him a comprehensive perspective on the needs of patients, physicians, and biotech companies who are the backbone of the clinical research industry.